Neuraminidase inhibitors rewire neutrophil function in vivo in murine sepsis and ex vivo in COVID-19 (2022)
- Authors:
- Formiga, Rodrigo Oliveira
- Amaral, Flávia Cardoso
- Souza, Camila F.
- Mendes, Daniel A. G. B.
- Wanderley, Carlos Wagner de Souza
- Lorenzini, Cristina B.
- Santos, Adara A.
- Antônia, Juliana
- Faria, Lucas F.
- Natale, Caio C.
- Paula, Nicholas M.
- Silva, Priscila C. S.
- Fonseca, Fernanda R.
- Aires, Luan
- Heck, Nicoli
- Starick, Márick R.
- Barroso, Shana P. C.
- Morrot, Alexandre
- Weyenbergh, Johan Van
- Sordi, Regina de
- Alisson-Silva, Frederico
- Mansur, Daniel S.
- Cunha, Fernando de Queiroz
- Rocha, Edroaldo L.
- Witko-Sarsat, Véronique
- Burgel, Pierre-Régis
- Martin, Clémance
- Maurici, Rosemeri
- Bafica, Andre
- Macauley, Matthew S.
- Spiller, Fernando
- USP affiliated authors: CUNHA, FERNANDO DE QUEIROZ - FMRP ; WANDERLEY, CARLOS WAGNER DE SOUZA - FMRP
- Unidade: FMRP
- DOI: 10.1101/2020.11.12.379115
- Subjects: GLICOSÍDEOS; SEPSE; NEUTRÓFILOS; COVID-19; ANTIVIRAIS
- Keywords: Neuraminidase; Sialic acid; Sepsis; Oseltamivir; Zanamivir; Neutrophil; SARS-CoV-2
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: other-oa
-
ABNT
FORMIGA, Rodrigo Oliveira et al. Neuraminidase inhibitors rewire neutrophil function in vivo in murine sepsis and ex vivo in COVID-19. bioRxiv, p. 1-68, 2022Tradução . . Disponível em: https://doi.org/10.1101/2020.11.12.379115. Acesso em: 28 dez. 2025. -
APA
Formiga, R. O., Amaral, F. C., Souza, C. F., Mendes, D. A. G. B., Wanderley, C. W. de S., Lorenzini, C. B., et al. (2022). Neuraminidase inhibitors rewire neutrophil function in vivo in murine sepsis and ex vivo in COVID-19. bioRxiv, 1-68. doi:10.1101/2020.11.12.379115 -
NLM
Formiga RO, Amaral FC, Souza CF, Mendes DAGB, Wanderley CW de S, Lorenzini CB, Santos AA, Antônia J, Faria LF, Natale CC, Paula NM, Silva PCS, Fonseca FR, Aires L, Heck N, Starick MR, Barroso SPC, Morrot A, Weyenbergh JV, Sordi R de, Alisson-Silva F, Mansur DS, Cunha F de Q, Rocha EL, Witko-Sarsat V, Burgel P-R, Martin C, Maurici R, Bafica A, Macauley MS, Spiller F. Neuraminidase inhibitors rewire neutrophil function in vivo in murine sepsis and ex vivo in COVID-19 [Internet]. bioRxiv. 2022 ; 1-68.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1101/2020.11.12.379115 -
Vancouver
Formiga RO, Amaral FC, Souza CF, Mendes DAGB, Wanderley CW de S, Lorenzini CB, Santos AA, Antônia J, Faria LF, Natale CC, Paula NM, Silva PCS, Fonseca FR, Aires L, Heck N, Starick MR, Barroso SPC, Morrot A, Weyenbergh JV, Sordi R de, Alisson-Silva F, Mansur DS, Cunha F de Q, Rocha EL, Witko-Sarsat V, Burgel P-R, Martin C, Maurici R, Bafica A, Macauley MS, Spiller F. Neuraminidase inhibitors rewire neutrophil function in vivo in murine sepsis and ex vivo in COVID-19 [Internet]. bioRxiv. 2022 ; 1-68.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1101/2020.11.12.379115 - Glycolytic tumor burden on pretreatment 18F-FDG PET/CT correlates with response and survival in metastatic NSCLC undergoing immune checkpoint inhibitors
- Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications
- Neuraminidase is a host‐directed approach to regulate neutrophil responses in sepsis and COVID‐19
- Platelets fuel the inflammasome activation of innate immune cells
- Nanobodies dismantle post-pyroptotic ASC specks and counteract inflammation in vivo
- Baseline glycolytic tumor burden predicts response and survival in NSCLC and melanoma patients treated with immune checkpoint inhibitors
- Tumor glycolytic profiling through 18F-FDG PET/CT predicts immune checkpoint inhibitor efficacy in advanced NSCLC
- Controle da migracao de neutrofilos por fatores liberados de macrofagos estimulados com endotoxina de escherichia coli
- Edema de pata em cobaias: modelo para estudos da reacao inflamatoria de origem imunologica
- Comparison of five methods for the determination of lethal dose in acute toxicity studies
Informações sobre o DOI: 10.1101/2020.11.12.379115 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003086584.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
